The Indian government is working with JPMorgan chase to potentially include its bonds in the firm's global indices, people with knowledge of the matter told Bloomberg News

India is aiming for a 7% weightage in the indices tracked by global investors, the sources said, adding that details have not yet been finalised and are subject to change.

Opening up of the sovereign bond market to overseas investors has so far attracted inflows worth $2.4 billion.

A previous attempt at inclusion in JPMorgan's indices had fizzled out in 2013 when Indian officials resisted removal of cap on foreign ownership.

Representatives of JPMorgan and the Finance Ministry were unavailable for comments.

• Trades at the highest level since April 2019
• Top gainer on the Nifty Media Index
• Gains as much as 15.3% to Rs 38.3
• Biggest single-day gain in two months
• Up for the third straight day
• Longest gaining streak in a month
• Has gained in five out of the last seven trading sessions
• Up 51% in the last seven trading sessions
• Has nearly quadrupled from its 52-week low of Rs 11.85 on March 25, 2020
• All three analysts tracking the stock have a buy recommendation

• Benchmark indices trade off the day's high
• Nifty up 1.6% to 9,965
• Sensex up 1.6% to 33,760
• Nifty Bank up 2.2% to 20,352
• Nifty Midcap Index up 1.6%
• Nifty Smallcap Index up 1.2%
• India Volatility Index down 4.5% to 31.1
• Nifty Media Index is the top sectoral gainer; up 3.4%
• Nifty Metal Index off the day's high but up 2.9%
• Nifty Auto, Nifty I.T. and Nifty PSU Bank gain 1% each
• JSW Steel is the top Nifty gainer; up 5.6%
• 42 out of the 50 Nifty constituents gain
• Tata Motors is the top Nifty laggard; down 4.3%
• 1,293 stocks on the NSE trade with gains while 446 decline

The company informed the exchanges on Monday that it is all set to commercially launch its key API - Fexofenadine in the U.S. Market.

Fexofenadine is an anti-histamine drug used in the treatment of seasonal allergic Rhinitis and Urticaria in the U.S. market.

The company has received commercial orders for the same and supplies will begin from the current quarter, according to its exchange filing.

U.S. market contributed 14% to the company's revenue where it supplies 7-8 products comfortably.

The stock is locked in an upper circuit of 10% at Rs 33.25 and is up for the second straight day.